Graf Akcie GILD (Gilead Sciences, Inc.). Diskuze k akciím GILD. Aktuální informace GILD.

Základní informace o společnosti Gilead Sciences, Inc. (Akcie GILD)

Skvělé pro velmi rychlou analýzu společnosti. Investor může porovnat různé ukazatele s konkurenčními firmami.

Tržní kapitalizace 85.38B
Hodnota podniku (EV) 113.59B
Tržby 26.638B
EBITDA 13.052B
Zisk 5.162B
Růst v tržbách Q/Q 20.88 %
Růst v tržbách Y/Y 20.13 %
P/E (Cena vůči ziskům) 16.42
Forward P/E 10.06
EV/Sales 4.26
EV/EBITDA 8.70
EV/EBIT 14.63
PEG 0.56
Price/Sales 3.21
P/FCF 10.08
Price/Book 4.69
Účetní hodnota na akcii 14.42
Hotovost na akcii 5.87
FCF vůči ceně 9.92 %
Počet zaměstnanců 13,600
Tržba na zaměstnance 1959000
Profit margin 0.50 %
Operating margin 36.74 %
Gross margin 81.48 %
EBIT margin 29.14 %
EBITDA margin 49.00 %
EPS - Zisk na akcii 4.12
EPS - Kvartální růst 68.47 %
EPS - Očekávaný růst příští rok -20.85 %
Return on assets 7.80 %
Return on equity 27.79 %
ROIC 4.14 %
ROCE 13.44 %
Dluhy/Equity 2.76
Čistý dluh/EBITDA 5.93
Current ratio 1.36
Quick Ratio 1.19
Volatilita 1.63
Beta 0.42
RSI 38.64
Cílová cena analytiků 73
Známka akcie (dle analytiků) 2.37
Insider ownership 0.10 %
Institutional ownership 81.00 %
Počet akcií 1.254B
Procento shortovaných akcií 1.79 %
Short ratio 3.74 %
Dividenda 2.81
Procentuální dividenda 4.12 %
Dividenda/Zisk 68.20 %
Obchodovaná od 1992
Země United States

Finanční výsledky akcie GILD

Finanční výsledky společnosti, napoví investorovi, zda se jedná o kvalitní společnost.

# 2020 2019 2018 2017 2016 2015
Revenue$24,689$22,449$22,127$26,107$30,390$32,639
Cost Of Goods Sold$4,572$4,675$4,853$4,371$4,261$4,006
Gross Profit$20,117$17,774$17,274$21,736$26,129$28,633
Research And Development Expenses$5,039$9,106$5,018$3,734$5,098$3,014
SG&A Expenses$5,151$4,381$4,056$3,878$3,398$3,426
Other Operating Income Or Expenses------
Operating Expenses$20,618$18,162$13,927$11,983$12,757$10,446
Operating Income$4,071$4,287$8,200$14,124$17,633$22,193
Total Non-Operating Income/Expense$-2,402$873$-401$-595$-536$-534
Pre-Tax Income$1,669$5,160$7,799$13,529$17,097$21,659
Income Taxes$1,580$-204$2,339$8,885$3,609$3,553
Income After Taxes$89$5,364$5,460$4,644$13,488$18,106
Other Income------
Income From Continuous Operations$89$5,364$5,460$4,644$13,488$18,106
Income From Discontinued Operations------
Net Income$123$5,386$5,455$4,628$13,501$18,108
EBITDA$4,071$5,691$9,629$15,410$18,791$23,291
EBIT$4,071$4,287$8,200$14,124$17,633$22,193
Basic Shares Outstanding1,2571,2701,2981,3071,3391,464
Shares Outstanding1,2631,2771,3081,3191,3581,521
Basic EPS$0.10$4.24$4.20$3.54$10.08$12.37
EPS - Earnings Per Share$0.10$4.22$4.17$3.51$9.94$11.91
# 2020 2019 2018 2017 2016 2015
Current Ratio3.10443.37922.73512.1252.50373.0748
Long-term Debt / Capital0.5050.54330.60460.57910.5290.4418
Debt/Equity Ratio1.13031.31711.66331.3761.17470.8221
Gross Margin79.17578.067583.257485.978987.726384.781
Operating Margin19.096637.058854.100458.022467.995461.3299
EBIT Margin19.096637.058854.100458.022467.995461.3299
EBITDA Margin25.350843.51759.026361.832871.359465.5484
Pre-Tax Profit Margin22.985435.246551.821456.258666.359359.6866
Net Profit Margin23.992224.653117.727144.425855.479648.6179
Asset Turnover0.36430.34750.37150.53340.63110.718
Inventory Turnover Ratio5.07055.96195.45692.68492.04912.733
Receiveable Turnover6.26726.65076.77936.73245.57555.37
Days Sales In Receivables58.2454.881153.840554.215565.464967.9701
ROE - Return On Equity23.682125.355322.652669.658694.731376.2311
Return On Tangible Equity112.9977325.1936-612.6649146.2907235.3262337.4091
ROA - Return On Assets8.7048.57486.607623.672735.010434.7883
ROI - Return On Investment11.723811.58068.955929.317944.614742.5497
Book Value Per Share17.89116.797215.673614.780913.440910.553
Operating Cash Flow Per Share0.7385-2.5985-3.5325-1.41816.18855.9507
Free Cash Flow Per Share0.7989-2.8576-3.429-1.47786.03565.7246

Porovnání s konkurencí: Akcie GILD

Společnost P/E PEG Růst v tržbách (roční) Růst v EPS Return on equity P/B Profit margin
GILD 16.42 0.56 20.13 % -20.85 % 27.79 % 4.69 0.50 %
Akcie ABBV 29.80 1.28 48.31 % 14.49 % 48.79 % 14.67 10.08 %
Akcie AMGN 20.99 1.66 4.87 % -2.29 % 60.57 % 12.44 28.57 %
Akcie ALXN 58.49 1.17 18.24 % 7.07 % 4.43 % 3.46 9.94 %
Akcie BIIB 22.07 6.24 -19.26 % -53.28 % 17.89 % 4.02 29.76 %
Akcie JNJ 23.93 1.67 10.79 % 7.27 % 27.01 % 6.67 17.82 %
Akcie ILMN 77.93 2.12 18.35 % 10.78 % 15.76 % 12.58 20.25 %
Akcie LLY 35.62 1.63 16.46 % 27.92 % 101.98 % 39.72 25.24 %
Akcie MRK 35.60 1.38 2.87 % 13.14 % 19.42 % 7.90 14.72 %
Akcie PFE 17.66 1.97 4.96 % 50.00 % 19.81 % 3.72 22.95 %
Akcie VRTX 23.68 0.36 23.71 % 15.91 % 22.76 % 5.35 43.70 %

Nedávné obchody insiderů: Akcie GILD

Jméno Obchod Cena Objem
Diane E. Wilfong
SVP, Controller, and CAO
Option
10 Nov 2020
$60.62 $86,687
Merdad Parsey
Chief Medical Officer
Option
10 Nov 2020
$60.62 $309,223
Andrew D Dickinson
EVP and Chief Financial Officer
Option
10 Nov 2020
$60.62 $184,649
Kevin E Lofton
Director
Option
22 Jan 2021
$20.65 $418,823
Sandra Horning
Director
Option
28 Jan 2021
$64.68 $40,878
Brett A Pletcher
EVP, Corp Affairs, and Gen Counsel
Prodej
1 Feb 2021
$65.97 $640,635
Andrew D Dickinson
EVP and Chief Financial Officer
Option
6 Feb 2021
$68.46 $124,460
Brett A Pletcher
EVP, Corp Affairs, and Gen Counsel
Option
6 Feb 2021
$68.46 $186,759
Diane E. Wilfong
SVP, Controller, and CAO
Option
6 Feb 2021
$68.46 $127,746
Brett A Pletcher
EVP, Corp Affairs, and Gen Counsel
Prodej
10 Feb 2021
$67.41 $133,135
Diane E. Wilfong
SVP, Controller, and CAO
Option
10 Feb 2021
$67.29 $52,352

Diskuze k akciím GILD